May 11, 2023

Catalyst CEO and Founder Nancy Bradish Myers provided her perspective on FDA hybrid/telework policies and the impact of any potential changes in the future. With over 2,000 vacancies at the agency, a hiring push is under way, particularly given new funding provided under PDUFA VII for hiring in certain areas. The article highlights the positive impact the hybrid work environment has had on FDA morale in recent years, but that there is a House-led effort to require federal workers to return to in-person, pre-COVID work arrangements (and the Administration would like to see employees work in person more often).  While the article cites a 2021 survey of FDA’s Centers showing that over a quarter of those staff would consider leaving the agency if they were permitted to work from home more often elsewhere, it also noted Ms. Myers’ view that “returning to the office may help the careers of young scientists who need mentorship that is difficult to provide over Zoom.”

Oops! Something went wrong while submitting the form.

Recent News

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Read more

Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace

Scientific innovation in Cell & Gene Therapy (C&GT) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions

Read more

Recent blogs

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Read more

Catalyst to Moderate DIA 2025 Panel on Enhancing Innovation in CGT Clinical Trials for Rare Disease

Join us for this dynamic conversation on Monday, June 16th, from 2:15–3:15 PM at DIA. We’d love to connect if you’ll be attending!

Read more

Catalyst to attend FDLI 2025 Annual Conference

If you are attending the FDLI conference, we would love to chat - reach out to us on LinkedIn!

Read more